4.4 Review

Inflammation, cancer, and bone loss

期刊

CURRENT OPINION IN PHARMACOLOGY
卷 9, 期 4, 页码 427-433

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.coph.2009.06.007

关键词

-

资金

  1. National Institute of Health (NIH) [R01-AR054326, R01-AR49192]
  2. Shriners Hospital for Children [8510, 8570]

向作者/读者索取更多资源

Skeletal distortions impose grave health disparities with potentially devastating consequences, including bone pain, immobility, and morbidity. Bone erosion is chiefly caused by hyperactive osteoclasts summoned to bone in response to circulating factors produced by tumor and inflammatory cells. Intense research in the past two decades has identified crucial elements and intricate circulatory systems that maintain and exacerbate inflammatory osteolysis. This progress led to better understanding of the mechanisms underlying this response and to developing advanced therapeutic interventions. Nevertheless, the multifactorial causes of inflammatory osteolysis continue to impose a great challenge for these therapies. This article provides an overview of some of the prominent facets contributing to this process.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据